19/20078
Anchor pharmaceutical research and development in Germany nationally and make it crisis-proof
Introduced
17 June 2020
Last action
—
Status
Erledigt durch Ablauf der Wahlperiode
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
Reducing the basic funding of the international vaccine initiative (CEPI) from 90 million euros to 50 million euros and making the freed-up funds available exclusively to German companies (SMEs), allocating additional funds of 145 million euros for the development of antibody tests and vaccines in Covid-19 research primarily to national research institutions, reducing bureaucratic hurdles and creating innovation-friendly framework conditions for pharmaceutical research and development
Machine translation from German. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
19/30272
19/30272
Drucksache · DE · 3 June 2021
19/20078
Drucksache · DE · 17 June 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.